-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WilMa6FqTrn1sJgUoHSBq/K7YsXR3M5ZoX+3qlJYFClNxbtSJeAsII56152lBjmf 5TiV8fg8/xLe9aH54FUEsQ== 0000950130-97-002554.txt : 19970523 0000950130-97-002554.hdr.sgml : 19970523 ACCESSION NUMBER: 0000950130-97-002554 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19970521 ITEM INFORMATION: Other events FILED AS OF DATE: 19970522 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: ROBERTS PHARMACEUTICAL CORP CENTRAL INDEX KEY: 0000853022 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222429994 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-10432 FILM NUMBER: 97612951 BUSINESS ADDRESS: STREET 1: MERIDIAN CENTRE II STREET 2: 4 INDUSTRIAL WAY W CITY: EATONTOWN STATE: NJ ZIP: 07724 BUSINESS PHONE: 9083891182 MAIL ADDRESS: STREET 1: MERIDIAN CTR II STREET 2: 4 INDUSTRIAL WAY WEST CITY: EATONTOWN STATE: NJ ZIP: 07724 8-K 1 FORM 8-K FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 21, 1997 ROBERTS PHARMACEUTICAL CORPORATION - -------------------------------------------------------------------------------- (exact name of registrant as specified in its charter) New Jersey 1-1-432 22-2429994 --------------- ----------- -------------- (State or other (Commission (IRS Employer jurisdiction of File Number) Identification incorporation) Number) Meridian Center II 4 Industrial Way West Eatontown New Jersey 07724 - -------------------------------------------------------------------------------- (Address of principal executive offices, including zip code) Registrant's telephone number, including area code: 908-389-1182 Meridian Center II 4 Industrial Way West Eatontown, New Jersey 07724 - -------------------------------------------------------------------------------- (Former name or former address, if changed from last report) -2- Item 5. Other Events ------------ Roberts Pharmaceutical Corporation announced today that Mr. Joseph N. Noonburg and the Honorable Marilyn Lloyd have joined its Board of Directors. Mr. Noonburg, a self employed consultant, has a 38 year background in the pharmaceutical industry. Mr. Noonburg is former Senior Vice President of Sales for the pharmaceutical firm of Reed & Carnick and General manager of Strafford Miller, Reed & Carnick's generic drug division. Mr. Noonburg has been actively involved in several pharmaceutical industry associations including, the Pharmaceutical Research and Manufacturers Association, National Wholesale Druggist Association and the National Association of Chain Drug Stores. Ms. Lloyd, a former Congresswoman, is a consultant for Lockheed Martin Corporation and the Spectrum Group and serves on a number of boards including the board of Lockheed Martin Energy Research Corporation. From 1974 through 1995, Ms. Lloyd represented Tennessee's Third Congressional District in the U.S. House of Representatives. In addition to being Chairman of the Energy Subcommittee of the House Science and Technology Committee, she championed many initiatives promoting health care awareness for women and chaired the Housing and Consumer Committee of the Committee on Aging. In addition to her corporate board positions, Ms. Lloyd is a member of Secretary Pena's Energy Advisory Board. Mr. Noonburg and Ms. Lloyd now fill the two seats on the Board of Directors previously held by Yamanouchi Group Holding, Roberts largest shareholder. Under the terms of a stock purchase agreement, Yamanouchi is now entitled to designate only one member of the board for election. Yamanouchi has noted its continued interest in Roberts future and, while not designating a nominee to Roberts Board at this time, retains the right to do so at a future date. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ROBERTS PHARMACEUTICAL CORPORATION ---------------------------------- (Registrant) Date: May 22, 1997 By: /s/ Anthony A. Rascio ---------------------------- Anthony A. Rascio Vice President -----END PRIVACY-ENHANCED MESSAGE-----